MicroRNAs in IPF and lung cancer: convergent and divergent mechanisms: a systematic review.
Sara Gangi, Sofia Marrucci, Chiara Diana et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examines the role of microRNAs (miRNAs) in idiopathic pulmonary fibrosis (IPF) and lung cancer (LC), highlighting shared and distinct mechanisms. It discusses how miRNAs regulate critical processes like epithelial-mesenchymal transition and TGF-β signaling. The review emphasizes the potential of circulating miRNA signatures as biomarkers and therapeutic targets, suggesting that specific miRNAs, such as miR-21 and miR-155, are implicated in both conditions.
Key findings
- Dysregulation of specific miRNAs, such as miR-21 and miR-155, is linked to both IPF and LC.
- Circulating miRNA signatures may serve as minimally invasive biomarkers for early detection and monitoring.
- Some miRNAs exhibit concordant expression patterns, promoting fibrosis and tumor progression.
- Others, like miR-204 5-p, show divergent roles in fibrotic and neoplastic contexts.
Why it matters
Understanding the role of miRNAs in IPF and LC can enhance early detection and risk stratification, potentially leading to improved patient management. The identification of shared mechanisms may also inform therapeutic strategies targeting these pathways.